Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Ratios

Hinge Health (HNGE) Cash from Operations (2024 - 2026)

Hinge Health's Cash from Operations history spans 2 years, with the latest figure at 63893000.0 for Q4 2025.

On a quarterly basis, Cash from Operations rose 66.65% to 63893000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 213028000.0, a N/A change, with the full-year FY2025 number at 171441000.0, up 249.87% from a year prior.
Cash from Operations hit 63893000.0 in Q4 2025 for Hinge Health, down from 82398000.0 in the prior quarter.
Over the last five years, Cash from Operations for HNGE hit a ceiling of 82398000.0 in Q3 2025 and a floor of 28398000.0 in Q3 2024.